Deaths among tuberculosis cases in Shanghai, China: who is at risk?

详细信息    查看全文

• 作者：Xin Shen (1)
  Kathryn DeRiemer (2)
  Zheng'an Yuan (1)
  Mei Shen (1)
  Zhen Xia (1)
  Xiaohong Gui (1)
  Lili Wang (1)
  Jian Mei (1)
  
• 刊名：BMC Infectious Diseases
• 出版年：2009
• 出版时间：December 2009
• 年：2009
• 卷：9
• 期：1
• 全文大小：188KB
• 参考文献：1. World Health Organization: Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009. Geneva, WHO 2009.
  2. World Health Organization: World Health Statistics 2008. Geneva, WHO 2008.
  3. Mathew TA, Ovsyanikova TN, Shin SS, Gelmanova I, Balbuena DA, Atwood S, Peremitin GG, Strelis AK, Murray MB: Causes of death during tuberculosis treatment in Tomsk Oblast, Russia. / Int J Tuberc Lung Dis 2006,10(8):857-63.
  4. Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, Weiner M, Vernon A: Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. / Int J Tuberc Lung Dis 2006,10(5):542-49.
  5. Hansel NN, Merriman B, Haponik EF, Diette GB: Hospitalizations for tuberculosis in the United States in 2000: predictors of in-hospital mortality. / Chest 2004,126(4):1079-086. CrossRef
  6. Lefebvre N, Falzon D: Risk factors for death among tuberculosis cases: analysis of European surveillance data. / Eur Respir J 2008,31(6):1256-260. CrossRef
  7. Borgdorff MW, Veen J, Kalisvaart NA, Nagelkerke N: Mortality among tuberculosis patients in The Netherlands in the period 1993-995. / Eur Respir J 1998,11(4):816-20. CrossRef
  8. Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE: Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. / Clin Infect Dis 2002,34(6):752-59. CrossRef
  9. Kolappan C, Subramani R, Kumaraswami V, Santha T, Narayanan PR: Excess mortality and risk factors for mortality among a cohort of TB patients from rural south India. / Int J Tuberc Lung Dis 2008,12(1):81-6.
  10. Website of 'Shanghai Municipal Health Bureau'[http://wsj.sh.gov.cn/website/]
  11. Website of 'Ministry of Health of the People's Republic of China'[http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjty/digest2000/Ty4-79.htm]
  12. Shen X, DeRiemer K, Yuan Z, Shen M, Xia Z, Gui X, Wang L, Gao Q, Mei J: Drug resistant tuberculosis in Shanghai, China, 2000-006: Prevalence, trends, and risk factors. / Int J Tuberc Lung Dis 2009,13(2):253-59.
  13. World Health Organization, International Union Against Tuberculosis and Lung Disease, Royal Netherlands Tuberculosis Association: Revised international definitions in tuberculosis control. / Int J Tuberc Lung Dis 2001,5(3):213-15.
  14. Crofts JP, Pebody R, Grant A, Watson JM, Abubakar I: Estimating tuberculosis case mortality in England and Wales, 2001-002. / Int J Tuberc Lung Dis 2008,12(3):308-13.
  15. Najera-Ortiz JC, Sanchez-Perez HJ, Ochoa-Diaz H, Arana-Cedeno M, Lezama MS, Mateo MM: Demographic, health services and socio-economic factors associated with pulmonary tuberculosis mortality in Los Altos Region of Chiapas, Mexico. / Int J Epidemiol 2008,37(4):786-95.
  16. Perez-Guzman C, Vargas MH, Torres-Cruz A, Villarreal-Velarde H: Does aging modify pulmonary tuberculosis?: A meta-analytical review. / Chest 1999,116(4):961-67. CrossRef
  17. Doherty MJ, Spence DP, Davies PD: Trends in mortality from tuberculosis in England and Wales: effect of age on deaths from non-respiratory disease. / Thorax 1995,50(9):976-79. CrossRef
  18. Leung CC, Yew WW, Chan CK, Chau CH, Tam CM, Lam CW, Tam WO, Lau KS, Liu WT: Tuberculosis in older people: a retrospective and comparative study from Hong Kong. / J Am Geriatr Soc 2002,50(7):1219-226. CrossRef
  19. Vasankari T, Holmstrom P, Ollgren J, Liippo K, Kokki M, Ruutu P: Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. / BMC Public Health 2007,7(147):291. CrossRef
  20. Walpola HC, Siskind V, Patel AM, Konstantinos A, Derhy P: Tuberculosis-related deaths in Queensland, Australia, 1989-998: characteristics and risk factors. / Int J Tuberc Lung Dis 2003,7(8):742-50.
  21. Balasubramanian R, Garg R, Santha T, Gopi PG, Subramani R, Chandrasekaran V, Thomas A, Rajeswari R, Anandakrishnan S, Perumal M, / et al.: Gender disparities in tuberculosis: report from a rural DOTS programme in south India. / Int J Tuberc Lung Dis 2004,8(3):323-32.
  22. White MC, Portillo CJ: Tuberculosis mortality associated with AIDS and drug or alcohol abuse: analysis of multiple cause-of-death data. / Public Health 1996,110(3):185-89. CrossRef
  23. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, / et al.: American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. / Am J Respir Crit Care Med 2003,167(4):603-62. CrossRef
  24. Dye C, Bassili A, Bierrenbach AL, Broekmans JF, Chadha VK, Glaziou P, P Gopi G, Hosseini M, Kim SJ, Manissero D, / et al.: Measuring tuberculosis burden, trends, and the impact of control programmes. / Lancet Infect Dis 2008,8(4):233-43. CrossRef
  25. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/9/95/prepub
  
• 作者单位：Xin Shen (1)
  Kathryn DeRiemer (2)
  Zheng'an Yuan (1)
  Mei Shen (1)
  Zhen Xia (1)
  Xiaohong Gui (1)
  Lili Wang (1)
  Jian Mei (1)
  
  1. Department of TB Control, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, PR China
  2. School of Medicine, University of California, One Shields Avenue, Davis, California, USA
  

文摘

Background Information about the risk factors associated with death caused by tuberculosis (TB) or death with TB would allow improvements in the clinical care of TB patients and save lives. The present study sought to identify characteristics associated with increased risk of death during anti-TB treatment in Shanghai, a city in China with one of the country's highest TB mortality rates. Methods We evaluated deaths among culture positive pulmonary TB cases that were diagnosed in Shanghai during 2000-004 and initiated anti-TB therapy. Demographic, clinical, mycobacteriological information and treatment outcomes were routinely collected through a mandatory reporting system. Results There were 7,999 culture positive pulmonary cases reported during the study period. The overall case fatality rate was 5.5% (440 cases), and approximately half (50.5%) of the deaths were attributed to causes other than TB. Eighty-six percent of the deaths were among TB cases age ?60 years. The significant independent risk factors for mortality during anti-TB treatment were advancing age, male sex, sputum smear positivity, and the presence of a comorbidity. Conclusion More vigorous clinical management and prevention strategies by both the TB control program and other public health programs are essential to improve TB treatment outcomes. Earlier suspicion, diagnosis and treatment of TB, especially among persons older than 60 years of age and those with a comorbid condition, could reduce deaths among TB patients.